E

EGF Theramed Health Corp
CNSX:TMED

Watchlist Manager
EGF Theramed Health Corp
CNSX:TMED
Watchlist
Price: 0.08 CAD Market Closed
Market Cap: CA$839.2k

TMED's latest stock split occurred on Jul 11, 2022

The company executed a 1-for-20 stock split, meaning that for every 20 shares held, investors received 1 new share.

Before the split, TMED traded at 0.015 per share. Afterward, the share price was about 0.15.

The adjusted shares began trading on Jul 11, 2022. This was TMED's 3rd stock split, following the previous one in Oct 24, 2019.

Last Splits:
Jul 11, 2022
1-for-20
Oct 24, 2019
1-for-100
Sep 19, 2016
1-for-15
Pre-Split Price
0.3 0.015
Post-Split Price
0.15
Before
After
Last Splits:
Jul 11, 2022
1-for-20
Oct 24, 2019
1-for-100
Sep 19, 2016
1-for-15

EGF Theramed Health Corp
Stock Splits History

TMED Stock Splits Timeline
Jul 11, 2022
Jul 11, 2022
Split 1-for-20
/0.05
Pre-Split Price
0.3 0.015
Post-Split Price
0.15
Before
After
Oct 24, 2019
Oct 24, 2019
Split 1-for-100
/0.01
Pre-Split Price
20 0.01
Post-Split Price
34.4
Before
After
Sep 19, 2016
Sep 19, 2016
Split 1-for-15
/0.066666666666667
Pre-Split Price
5 550 0.185
Post-Split Price
5 500
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 24, 2026
Cue Biopharma Inc
NASDAQ:CUE
1-for-30
/30
0.5542 16.626 USD 17.695 17.695 USD
Apr 24, 2026
Medical Data Vision Co Ltd
TSE:3902
2-for-7253607
/3626803.5
1684 1684 JPY N/A
Apr 24, 2026
E
ESGL Holdings Ltd
NASDAQ:ESGL
1-for-3
/3
2.35 7.05 USD 2.93 2.93 USD
Apr 24, 2026
Metro Mining Ltd
ASX:MMI
1-for-20
/20
0.067 1.34 AUD 1.3 1.3 AUD
Apr 24, 2026
L
La Comer SAB de CV
OTC:LCMRF
115-for-114
x1.0087719298246
2.4715 2.4341 USD 2.45 2.45 USD
Load More

EGF Theramed Health Corp
Glance View

Market Cap
839.2k CAD
Industry
N/A

EGF Theramed Health Corp. is a health technology company, which engages in the provision of online services for monitoring and treating common health problems. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2013-06-20. The firm develops products, technologies and diagnostic tools that are focused on personalized medical care, including research with natural health and wellness products. The company is focused on research on psilocybin and psychedelic extraction, and processing for commercialization. The Company’s subsidiaries include Hemp Extraction Technology Corp. (HETC), Western Agri Supply Solutions Inc. (WASS) and Medical Green Natural List Corp. (MGNL).

TMED Intrinsic Value
0.03 CAD
Overvaluation 61%
Intrinsic Value
Price CA$0.08
E
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett